Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial

Detalhes bibliográficos
Autor(a) principal: Bastos,Jaime Freitas
Data de Publicação: 2016
Outros Autores: Ferri,Mauricio, Lima,José Jayme Galvão de, Kopel,Liliane, Lage,Silvia Gelás
Tipo de documento: Artigo
Idioma: eng
Título da fonte: MedicalExpress (São Paulo. Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000200007
Resumo: OBJECTIVES: Acute heart failure is associated with low cardiac output syndrome and renal dysfunction. However, it is not known whether a goal-directed protocol guided by tightly controlled hemodynamic variables, including pulmonary artery catheter, will safely improve clinical renal dysfunction markers in these patients when compared to a less invasive approach. METHODS: Pilot, randomized clinical trial aimed at patients with known heart failure, low cardiac output syndrome and renal dysfunction with less than 48 hours from onset. We randomized two groups: (a) goal-directed therapy monitored with pulmonary artery catheter and (b) conventional therapy with central venous catheter. Hemodynamic parameters, venous oxygen saturation, serum lactate, fluid repositions and vasoactive drugs were compared considering renal function improvement after 72 hours as the primary study endpoint. We included 15 goal-directed therapy and 16 conventional therapy patients. The study has assessed patients on baseline looking for significant improvement at 72 hours of the following parameters in the goal-directed therapy and conventional therapy groups: urine output, serum creatinine, venous oxygen saturation and serum lactate. RESULTS: Baseline characteristics were similar in both groups. In the first 24 hours there was a lower volume of fluid reposition in the goal-directed therapy group, although 72 hours later such reposition was equivalent. The use of inotropic agents was similar between groups. There was an improvement to the renal function and the hemodynamic parameter in both study groups. CONCLUSIONS: The option for the protocol with pulmonary artery catheter setting is justified only if there is clinical evidence of serious pulmonary congestion associated to low peripheral perfusion.
id METC-1_289aed837a4f1ad37f4963f396a554c8
oai_identifier_str oai:scielo:S2358-04292016000200007
network_acronym_str METC-1
network_name_str MedicalExpress (São Paulo. Online)
repository_id_str
spelling Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trialCardiogenic shockPulmonary artery catheterMonitoring hemodynamicHeart failureacute kidney injury OBJECTIVES: Acute heart failure is associated with low cardiac output syndrome and renal dysfunction. However, it is not known whether a goal-directed protocol guided by tightly controlled hemodynamic variables, including pulmonary artery catheter, will safely improve clinical renal dysfunction markers in these patients when compared to a less invasive approach. METHODS: Pilot, randomized clinical trial aimed at patients with known heart failure, low cardiac output syndrome and renal dysfunction with less than 48 hours from onset. We randomized two groups: (a) goal-directed therapy monitored with pulmonary artery catheter and (b) conventional therapy with central venous catheter. Hemodynamic parameters, venous oxygen saturation, serum lactate, fluid repositions and vasoactive drugs were compared considering renal function improvement after 72 hours as the primary study endpoint. We included 15 goal-directed therapy and 16 conventional therapy patients. The study has assessed patients on baseline looking for significant improvement at 72 hours of the following parameters in the goal-directed therapy and conventional therapy groups: urine output, serum creatinine, venous oxygen saturation and serum lactate. RESULTS: Baseline characteristics were similar in both groups. In the first 24 hours there was a lower volume of fluid reposition in the goal-directed therapy group, although 72 hours later such reposition was equivalent. The use of inotropic agents was similar between groups. There was an improvement to the renal function and the hemodynamic parameter in both study groups. CONCLUSIONS: The option for the protocol with pulmonary artery catheter setting is justified only if there is clinical evidence of serious pulmonary congestion associated to low peripheral perfusion.Mavera Edições Técnicas e Científicas Ltda2016-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000200007MedicalExpress v.3 n.2 2016reponame:MedicalExpress (São Paulo. Online)instname:Mavera Edições Científicas e Técnicas Ltda-MEinstacron:METC10.5935/MedicalExpress.2016.02.07info:eu-repo/semantics/openAccessBastos,Jaime FreitasFerri,MauricioLima,José Jayme Galvão deKopel,LilianeLage,Silvia Geláseng2016-04-07T00:00:00Zoai:scielo:S2358-04292016000200007Revistahttp://www.medicalexpress.net.brhttps://old.scielo.br/oai/scielo-oai.php||medicalexpress@me.net.br2358-04292318-8111opendoar:2016-04-07T00:00MedicalExpress (São Paulo. Online) - Mavera Edições Científicas e Técnicas Ltda-MEfalse
dc.title.none.fl_str_mv Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial
title Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial
spellingShingle Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial
Bastos,Jaime Freitas
Cardiogenic shock
Pulmonary artery catheter
Monitoring hemodynamic
Heart failure
acute kidney injury
title_short Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial
title_full Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial
title_fullStr Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial
title_full_unstemmed Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial
title_sort Goal-directed therapy for decompensated heart failure and renal dysfunction. A pilot randomized clinical trial
author Bastos,Jaime Freitas
author_facet Bastos,Jaime Freitas
Ferri,Mauricio
Lima,José Jayme Galvão de
Kopel,Liliane
Lage,Silvia Gelás
author_role author
author2 Ferri,Mauricio
Lima,José Jayme Galvão de
Kopel,Liliane
Lage,Silvia Gelás
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Bastos,Jaime Freitas
Ferri,Mauricio
Lima,José Jayme Galvão de
Kopel,Liliane
Lage,Silvia Gelás
dc.subject.por.fl_str_mv Cardiogenic shock
Pulmonary artery catheter
Monitoring hemodynamic
Heart failure
acute kidney injury
topic Cardiogenic shock
Pulmonary artery catheter
Monitoring hemodynamic
Heart failure
acute kidney injury
description OBJECTIVES: Acute heart failure is associated with low cardiac output syndrome and renal dysfunction. However, it is not known whether a goal-directed protocol guided by tightly controlled hemodynamic variables, including pulmonary artery catheter, will safely improve clinical renal dysfunction markers in these patients when compared to a less invasive approach. METHODS: Pilot, randomized clinical trial aimed at patients with known heart failure, low cardiac output syndrome and renal dysfunction with less than 48 hours from onset. We randomized two groups: (a) goal-directed therapy monitored with pulmonary artery catheter and (b) conventional therapy with central venous catheter. Hemodynamic parameters, venous oxygen saturation, serum lactate, fluid repositions and vasoactive drugs were compared considering renal function improvement after 72 hours as the primary study endpoint. We included 15 goal-directed therapy and 16 conventional therapy patients. The study has assessed patients on baseline looking for significant improvement at 72 hours of the following parameters in the goal-directed therapy and conventional therapy groups: urine output, serum creatinine, venous oxygen saturation and serum lactate. RESULTS: Baseline characteristics were similar in both groups. In the first 24 hours there was a lower volume of fluid reposition in the goal-directed therapy group, although 72 hours later such reposition was equivalent. The use of inotropic agents was similar between groups. There was an improvement to the renal function and the hemodynamic parameter in both study groups. CONCLUSIONS: The option for the protocol with pulmonary artery catheter setting is justified only if there is clinical evidence of serious pulmonary congestion associated to low peripheral perfusion.
publishDate 2016
dc.date.none.fl_str_mv 2016-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000200007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000200007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/MedicalExpress.2016.02.07
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Mavera Edições Técnicas e Científicas Ltda
publisher.none.fl_str_mv Mavera Edições Técnicas e Científicas Ltda
dc.source.none.fl_str_mv MedicalExpress v.3 n.2 2016
reponame:MedicalExpress (São Paulo. Online)
instname:Mavera Edições Científicas e Técnicas Ltda-ME
instacron:METC
instname_str Mavera Edições Científicas e Técnicas Ltda-ME
instacron_str METC
institution METC
reponame_str MedicalExpress (São Paulo. Online)
collection MedicalExpress (São Paulo. Online)
repository.name.fl_str_mv MedicalExpress (São Paulo. Online) - Mavera Edições Científicas e Técnicas Ltda-ME
repository.mail.fl_str_mv ||medicalexpress@me.net.br
_version_ 1754734597037359104